Tibet Cheezheng Tibetan Medicine Co Ltd (002287) — Cash Flow-to-Debt Ratio
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥34.69 Million could theoretically repay 0% of its total liabilities (CN¥1.78 Billion) in one year. See free cash flow generation of Tibet Cheezheng Tibetan Medicine Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Tibet Cheezheng Tibetan Medicine Co Ltd across 20 annual periods. Also explore 002287 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Year-by-year debt coverage analysis for Tibet Cheezheng Tibetan Medicine Co Ltd. For market capitalisation and broader financial context, see Tibet Cheezheng Tibetan Medicine Co Ltd (002287) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | CN¥729.70 Million | CN¥1.92 Billion | ▲ +122.7% |
| 2024 | 0.17x | CN¥456.75 Million | CN¥2.68 Billion | ▼ -37.8% |
| 2023 | 0.27x | CN¥693.41 Million | CN¥2.53 Billion | ▲ +139.9% |
| 2022 | 0.11x | CN¥285.69 Million | CN¥2.50 Billion | ▼ -74.1% |
| 2021 | 0.44x | CN¥1.03 Billion | CN¥2.35 Billion | ▲ +237.1% |
| 2020 | 0.13x | CN¥238.65 Million | CN¥1.82 Billion | ▼ -76.7% |
| 2019 | 0.56x | CN¥405.95 Million | CN¥722.20 Million | ▼ -69.9% |
| 2018 | 1.87x | CN¥499.40 Million | CN¥267.54 Million | ▲ +227.1% |
| 2017 | 0.57x | CN¥229.83 Million | CN¥402.78 Million | ▼ -52.4% |
| 2016 | 1.20x | CN¥389.20 Million | CN¥324.33 Million | ▲ +95.0% |
| 2015 | 0.62x | CN¥257.81 Million | CN¥419.05 Million | ▼ -52.1% |
| 2014 | 1.28x | CN¥310.95 Million | CN¥242.20 Million | ▼ -44.2% |
| 2013 | 2.30x | CN¥198.48 Million | CN¥86.34 Million | ▲ +9.6% |
| 2012 | 2.10x | CN¥169.67 Million | CN¥80.90 Million | ▲ +1529.7% |
| 2011 | -0.15x | CN¥-11.74 Million | CN¥80.01 Million | ▼ -116.8% |
| 2010 | 0.88x | CN¥96.91 Million | CN¥110.72 Million | ▼ -23.9% |
| 2009 | 1.15x | CN¥175.58 Million | CN¥152.68 Million | ▲ +72.7% |
| 2008 | 0.67x | CN¥65.93 Million | CN¥99.02 Million | ▼ -13.8% |
| 2007 | 0.77x | CN¥91.43 Million | CN¥118.37 Million | ▲ +169.6% |
| 2006 | 0.29x | CN¥38.50 Million | CN¥134.37 Million | — |